Live
- Physical fitness mandatory for cops: SP Jagadeesh
- Children’s Day celebrated at Ananthalakshmi School
- AHUDA chief Varun gets grand welcome
- Instil moral values in students
- Somishetty takes charge as KUDA chairman
- Foundation partners with BBMP to revamp Bengaluru’s iconic Church Street
- World Diabetes Day observed at Gem Care Kamineni Hospital
- Rural students told to pursue higher education
- Fishery activities get a big boost in TDP budget
- Today’s welfare measures aim to empower: Nirmala Sitharaman
EU to recommend 2nd COVID-19 booster for over-60s, top health official says
Representative image
"Today ECDC and EMA will recommend an additional booster to protect the most vulnerable," said the commissioner, Stella Kyriakides, referring to the European Centre for Disease Prevention and Control and the European Medicines Agency. The agencies are set to issue a joint statement at 0900 GMT on Monday.
European Union health agencies will recommend on Monday a second COVID-19 booster for everyone above 60 amid a new spike in infections and hospitalizations across Europe, the EU health commissioner said. "Today ECDC and EMA will recommend an additional booster to protect the most vulnerable," said the commissioner, Stella Kyriakides, referring to the European Centre for Disease Prevention and Control and the European Medicines Agency.
The agencies are set to issue a joint statement at 0900 GMT on Monday. "It is crucial that everyone above 60 and all vulnerable persons come forth for a second booster dose as quickly as possible," Kyriakides said in a statement.
EU health agencies have since April recommended a second booster only for those older than 80 and the most vulnerable. The new recommendation is expected to facilitate national decisions to speed up vaccination campaigns, which have been slowing to nearly a halt in recent months.
"We need to act now to boost the protection of citizens at risk over the summer months," Kyriakides said. She noted that vaccines currently available for boosters, such as Pfizer's and Moderna's, are "highly effective in reducing severe COVID."
It is however unclear how effective they are at preventing infections from the newest COVID-19 Omicron sub-variants.
